CV Sciences, Inc. (CVSI) stock
CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-21.13%)
Close on Oct 19, 2026Market cap $2.53MP/E –Yield –
CV Sciences total assets
Total assets on the balance sheet at the end of each period.
CV Sciences's total assets was $6.43M at Sep 30, 2026. For fiscal 2025 it was $6.96M, down 12.2% from the year before. Over ten years it grew -12.8% a year on average. The highest annual figure on record is $52.69M in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.96M | -12.2% |
| FY2024 | Dec 31, 2024 | $7.93M | -13.8% |
| FY2023 | Dec 31, 2023 | $9.20M | -27.8% |
| FY2022 | Dec 31, 2022 | $12.74M | -29.5% |
| FY2021 | Dec 31, 2021 | $18.07M | -41.0% |
| FY2020 | Dec 31, 2020 | $30.63M | -41.9% |
| FY2019 | Dec 31, 2019 | $52.69M | +42.8% |
| FY2018 | Dec 31, 2018 | $36.90M | +62.5% |
| FY2017 | Dec 31, 2017 | $22.71M | +22.1% |
| FY2016 | Dec 31, 2016 | $18.59M | -31.9% |
| FY2015 | Dec 31, 2015 | $27.30M | +25.6% |
| FY2014 | Dec 31, 2014 | $21.74M | +52.8% |
| FY2013 | Dec 31, 2013 | $14.23M | +3301994.7% |
| FY2012 | Dec 31, 2012 | $431 | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.43M | -8.0% |
| Q2 FY2026 | Jun 30, 2026 | $6.52M | -18.0% |
| Q1 FY2026 | Mar 31, 2026 | $6.72M | -13.4% |
| Q4 FY2025 | Dec 31, 2025 | $6.96M | -12.2% |
| Q3 FY2025 | Sep 30, 2025 | $7.00M | -16.6% |
| Q2 FY2025 | Jun 30, 2025 | $7.95M | -10.5% |
| Q1 FY2025 | Mar 31, 2025 | $7.76M | -8.3% |
| Q4 FY2024 | Dec 31, 2024 | $7.93M | -13.8% |
| Q3 FY2024 | Sep 30, 2024 | $8.39M | -13.0% |
| Q2 FY2024 | Jun 30, 2024 | $8.89M | -10.1% |
| Q1 FY2024 | Mar 31, 2024 | $8.47M | -26.2% |
| Q4 FY2023 | Dec 31, 2023 | $9.20M | -27.8% |
| Q3 FY2023 | Sep 30, 2023 | $9.64M | -36.5% |
| Q2 FY2023 | Jun 30, 2023 | $9.88M | -37.3% |
| Q1 FY2023 | Mar 31, 2023 | $11.47M | -37.2% |
| Q4 FY2022 | Dec 31, 2022 | $12.74M | -29.5% |
| Q3 FY2022 | Sep 30, 2022 | $15.18M | -35.7% |
| Q2 FY2022 | Jun 30, 2022 | $15.76M | -43.3% |
| Q1 FY2022 | Mar 31, 2022 | $18.27M | -40.5% |
| Q4 FY2021 | Dec 31, 2021 | $18.07M | -41.0% |
| Q3 FY2021 | Sep 30, 2021 | $23.61M | -38.5% |
| Q2 FY2021 | Jun 30, 2021 | $27.81M | -39.1% |
| Q1 FY2021 | Mar 31, 2021 | $30.68M | -35.4% |
| Q4 FY2020 | Dec 31, 2020 | $30.63M | -41.9% |
| Q3 FY2020 | Sep 30, 2020 | $38.41M | -32.1% |
| Q2 FY2020 | Jun 30, 2020 | $45.70M | -12.2% |
| Q1 FY2020 | Mar 31, 2020 | $47.52M | -1.8% |
| Q4 FY2019 | Dec 31, 2019 | $52.69M | +42.8% |
| Q3 FY2019 | Sep 30, 2019 | $56.54M | +82.2% |
| Q2 FY2019 | Jun 30, 2019 | $52.06M | +92.6% |
| Q1 FY2019 | Mar 31, 2019 | $48.39M | +109.9% |
| Q4 FY2018 | Dec 31, 2018 | $36.90M | +62.5% |
| Q3 FY2018 | Sep 30, 2018 | $31.04M | +52.1% |
| Q2 FY2018 | Jun 30, 2018 | $27.03M | +40.4% |
| Q1 FY2018 | Mar 31, 2018 | $23.05M | +20.2% |
| Q4 FY2017 | Dec 31, 2017 | $22.71M | +22.1% |
| Q3 FY2017 | Sep 30, 2017 | $20.41M | – |
| Q2 FY2017 | Jun 30, 2017 | $19.25M | – |
| Q1 FY2017 | Mar 31, 2017 | $19.17M | – |
| Q4 FY2016 | Dec 31, 2016 | $18.59M | – |
See a number that looks wrong?